Manejo anestésico en paciente con miocardiopatía periparto

Abstract

In order to describe the pathophysiology of peripartum cardiomyophaty -a low incidence disease-and the importance of anesthetic management, these patients underwent the following bibliography review. It was concluded that despite being a rare disease, it has high mortality in pregnant women who should be treated with low molecular weight heparin due to the incidence of teratogenicity with other anticoagulants, as well as the first line treatment needed. The anesthetic management is crucial to maintain an adequate preload and afterload, as well as the determination of the type of anesthesia that can be offered to the patient taking into account the laboratory studies to be able to choose regional techniques -which in these cases, is ideal-Being prepared to handle any complications and have the necessary adjuvants available to improve and maintain an adequate hemodynamic state.